210 related articles for article (PubMed ID: 16672230)
1. The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.
Van den Steen PE; Van Aelst I; Hvidberg V; Piccard H; Fiten P; Jacobsen C; Moestrup SK; Fry S; Royle L; Wormald MR; Wallis R; Rudd PM; Dwek RA; Opdenakker G
J Biol Chem; 2006 Jul; 281(27):18626-37. PubMed ID: 16672230
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the binding of hemopexin-like domain of gelatinase B cloned and expressed in Pichia pastoris to tissue inhibitor of metalloproteinases-1.
Stute J; Pourmotabbed T; Tschesche H
J Protein Chem; 2003 Aug; 22(6):509-14. PubMed ID: 14703983
[TBL] [Abstract][Full Text] [Related]
3. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
4. The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Roeb E; Schleinkofer K; Kernebeck T; Pötsch S; Jansen B; Behrmann I; Matern S; Grötzinger J
J Biol Chem; 2002 Dec; 277(52):50326-32. PubMed ID: 12384502
[TBL] [Abstract][Full Text] [Related]
5. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
Dufour A; Sampson NS; Zucker S; Cao J
J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
[TBL] [Abstract][Full Text] [Related]
6. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
7. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
8. Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins.
Piccard H; Van den Steen PE; Opdenakker G
J Leukoc Biol; 2007 Apr; 81(4):870-92. PubMed ID: 17185359
[TBL] [Abstract][Full Text] [Related]
9. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.
Kai HS; Butler GS; Morrison CJ; King AE; Pelman GR; Overall CM
J Biol Chem; 2002 Dec; 277(50):48696-707. PubMed ID: 12374789
[TBL] [Abstract][Full Text] [Related]
10. The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein.
Mantuano E; Inoue G; Li X; Takahashi K; Gaultier A; Gonias SL; Campana WM
J Neurosci; 2008 Nov; 28(45):11571-82. PubMed ID: 18987193
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains.
Martens E; Leyssen A; Van Aelst I; Fiten P; Piccard H; Hu J; Descamps FJ; Van den Steen PE; Proost P; Van Damme J; Liuzzi GM; Riccio P; Polverini E; Opdenakker G
Biochim Biophys Acta; 2007 Feb; 1770(2):178-86. PubMed ID: 17137715
[TBL] [Abstract][Full Text] [Related]
12. Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.
Higashi S; Miyazaki K
J Biol Chem; 2008 Apr; 283(15):10068-78. PubMed ID: 18238779
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue.
Scilabra SD; Yamamoto K; Pigoni M; Sakamoto K; Müller SA; Papadopoulou A; Lichtenthaler SF; Troeberg L; Nagase H; Kadomatsu K
Matrix Biol; 2017 May; 59():69-79. PubMed ID: 27476612
[TBL] [Abstract][Full Text] [Related]
14. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain.
Patterson ML; Atkinson SJ; Knäuper V; Murphy G
FEBS Lett; 2001 Aug; 503(2-3):158-62. PubMed ID: 11513874
[TBL] [Abstract][Full Text] [Related]
15. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.
Morrison CJ; Overall CM
J Biol Chem; 2006 Sep; 281(36):26528-39. PubMed ID: 16825197
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
[TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
18. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
[TBL] [Abstract][Full Text] [Related]
19. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells.
Rozanov DV; Hahn-Dantona E; Strickland DK; Strongin AY
J Biol Chem; 2004 Feb; 279(6):4260-8. PubMed ID: 14645246
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
